NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION
Farida Mirzakarimova, Светлана Петровна Каледа, Natalia Polikarpova, Abdumurad Babadjanov
Abstract
Farida Mirzakarimova, Светлана Петровна Каледа, Natalia Polikarpova, Abdumurad Babadjanov
Abstract
Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").
Key concepts: Nonalcoholic fatty liver disease, Metabolic syndrome, Insulin resistance, Disease, Medicine, Diabetes mellitus, Fatty liver, Internal medicine